Insights: Stories
Mayo Clinic Laboratories combines the expertise of world-renowned laboratorians and physicians to provide answers for patients’ serious and complex medical challenges.
These are the stories of the people throughout that journey — from the laboratorians conducting tests and delivering results, to the physicians guiding diagnosis and treatment, to the patients worldwide who need answers.
Most recent posts
Viral and pharmacogenomic testing help clinicians detect infection early, tailor immunosuppression, and improve long-term outcomes for organ transplant recipients.
Since overcoming a life-threatening diagnosis five years ago, Jim Smith has embraced life. But each time he travels to Mayo Clinic for follow-up laboratory testing, a well of emotions rises up to remind him of life’s fragility. Thankfully, through streamlined, accurate testing and top-notch clinical care, those feelings are generally short-lived.
As an event management coordinator for the Department of Laboratory Medicine and Pathology at Mayo Clinic, Jason Majorowicz acts as an investigator when something may deviate from its established process. With a background in biotechnology and over 20 years of experience at Mayo Clinic, Jason helps with process improvement, quality assurance, and problem-solving.
This week's research roundup features: Alliance A071401: phase II trial of focal adhesion kinase inhibition in meningiomas with somatic NF2 mutations
This week's research roundup features: Automated scoring of total inflammation in renal allograft biopsies
Elise Bieri Patzke has worked at Mayo Clinic for 17 years and is currently a project manager in Mayo Clinic BioPharma Diagnostics. She enjoys collaborating with her laboratory colleagues to pursue test development projects and biopharma opportunities that support the advancement of health care.
This week's research roundup features: How do I warm HPC(A) products to maximize cell viability in the setting of cold agglutinin disease?
In a groundbreaking study, Mayo Clinic investigators have developed a multiomic molecular method to predict clinical COVID-19 (SARS-CoV-2) outcomes better than traditional cytokines. Using a machine-learning-based prediction model, the team identified 102 biomarkers, which include several novel cytokines and other proteins, lipids, and metabolites. The discovery may help clinicians reliably predict a more severe course of COVID-19 before the patient gets sick enough to be hospitalized. Until now, there have been no biomarkers that can reliably predict which patients are more likely to have severe illness.
This week's research roundup features: Transcriptomic analysis of cirrhosis-like hepatocellular carcinoma reveals distinct molecular characteristics and pathologic staging implications
Deb Wells is the director of Quality Management Services at Mayo Clinic Laboratories. A science lover from a young age, Deb has long worked in medical laboratory science and is passionate about being an advocate for lab safety and quality.
This week's research roundup features: Tumor microenvironment CD14+ cells correlate with poor overall survival in patients with early-stage lung adenocarcinoma
Two years ago, when 29-year-old Meckenzie Tinaglia experienced a series of seizure-like events shortly after a cardiac ablation procedure, she knew her heart was to blame. Her local providers, however, weren’t convinced. If not for Mayo Clinic remote cardiac monitoring and the data it provided about Meckenzie’s potentially fatal arrythmia, the busy wife and young mother might not have survived.
This week's research roundup features: Robotics in neurosurgery: current prevalence and future directions